Endocannabinoids and non-endocannabinoid fatty acid amides in cirrhosis.
Ying-Ying
Yang
Y
Lin
Han-Chien
HC
D000577:Amides; D001095:Arachidonic Acids / Q000378:metabolism; D015415:Biomarkers / Q000097:blood; D063385:Cannabinoid Receptor Modulators / Q000097:blood / Q000378:metabolism*; D063388:Endocannabinoids; D004983:Ethanolamines / Q000378:metabolism; D005989:Glycerides / Q000378:metabolism; D006439:Hemodynamics; D006801:Humans; D019934:International Normalized Ratio; D008099:Liver / Q000098:blood supply / Q000378:metabolism* / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000097:blood / Q000378:metabolism* / Q000503:physiopathology; D009829:Oleic Acids; D010169:Palmitic Acids / Q000378:metabolism; D053284:Polyunsaturated Alkamides / Q000378:metabolism; D012720:Severity of Illness Index; D015854:Up-Regulation
D000577:Amides; D001095:Arachidonic Acids; D015415:Biomarkers; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D004983:Ethanolamines; D005989:Glycerides; D009829:Oleic Acids; D010169:Palmitic Acids; D053284:Polyunsaturated Alkamides; C033595:N-oleoylethanolamine; C005958:palmidrol; C094503:glyceryl 2-arachidonate; C078814:anandamide